Even when a new product or other innovation has been developed and proven in field tests, significant barriers often prevent its large-scale application among the populations that will benefit most. Challenges exist both in expanding the reach of intervention-focused programs, and fostering integration and reinforcement of the broader health system. Under this portfolio area, the PRN seeks to understand the binding constraints on "scale-up," and propose efficient ways for donors and international agencies to address these problems.
Sample topics:
- How can new resources available for purchase of ARVs, ACTs and other high-value products be employed most effectively, addressing weak links in the supply chain?
- How efficient is product uptake in developing countries? How can inefficiencies be measured and systematically addressed through donor actions?
- Can and should commercial product marketing principles be adapted to improve uptake of new global health products in the developing world?
- How can categorical or "vertical" programs be designed, financed and implemented so that they (a) most efficiently use existing infrastructure and human resources; and (b) contribute to the long-term development of the health system, to yield better health and development outcomes?
- What is the potential for demand-side and/or provider incentives to be used to increase uptake and expansion of immunization and other preventive services, particularly to very low-income populations where demand for preventive services is low?
- What standards should guide the types of interventions that would be introduced into health systems (i.e. indicators of "readiness" to implement a given type of program)? How could such standards be implemented?